Please try another search
Spring Pharmaceutical Group, Inc., through its subsidiaries, engages in the research, development, manufacture, and sale of Chinese medicines primarily made from ginseng leaves extract in the People's Republic of China. The company offers Huoliyuan capsule, an herbal medicine for the treatment of chronic hepatitis, diabetes, insomnia, memory loss, menopause syndrome, and other maladies; ginkgo herbal tea; and truncatum bunge seed oils. It also develops acer truncatum bunge planting bases; and distributes health care supplement products. The company sells its products to customers through distributors. The company was formerly known as China YCT International Group, Inc. and changed its name to Spring Pharmaceutical Group, Inc. in August 2018. Spring Pharmaceutical Group, Inc. was incorporated in 1989 and is based in Sishui, the People's Republic of China.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review